Amino-acid-based dialysis solution changes leptinemia and leptin peritoneal clearance

Area of Science:

• Nephrology
• Endocrinology
• Nutritional Science

Background:

• Continuous ambulatory peritoneal dialysis (CAPD) impacts nutritional status and solute transport.
• Leptin plays a role in appetite and energy balance, and its levels may be affected by dialysis treatments.

Purpose of the Study:

• To investigate the effect of amino-acid-based dialysis solution (AADS) on serum and dialysate leptin concentrations in CAPD patients.
• To assess changes in leptinemia and peritoneal transport indices during AADS treatment.

Main Methods:

• Prospective study of nine CAPD patients over four periods: before, during (3 and 6 months), and after AADS treatment.
• Measured serum and dialysate leptin concentrations, anorexia incidence, nutrient intake, and nutritional parameters.
• Calculated dialysate-to-plasma ratio (D/P), peritoneal excretion, and clearance (PCl) of leptin.

Main Results:

• AADS administration led to a transient decrease in serum leptin (leptinemia) after 3 months.
• Peritoneal excretion and clearance (PCl) of leptin significantly increased during AADS treatment.
• The positive correlation between serum leptin and total body fat mass was disrupted during AADS administration.

Conclusions:

• AADS treatment in CAPD patients transiently lowers serum leptin and enhances leptin removal via peritoneal dialysis.
• AADS administration alters the established relationship between leptin levels and body fat mass in CAPD patients.